Effect of Aminophylline Bolus Versus Infusion on Recovery Time in Patients Undergoing Lumbar Spine Surgery

NCT ID: NCT05655806

Last Updated: 2023-01-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

33 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-12-30

Study Completion Date

2023-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To determine optimal dose, method and time of administration of aminophylline to enhance the recovery from general anesthesia.

andTo estimate the recovery time from isoflurane closure in each group. We hypothesize that starting administration of loading and maintenance dose of aminophylline half an hour before discontinuing isoflurane will shorten the duration needed to extubate patients undergoing lumbar disc surgery. We hypothesized that it will yield superior results compared to bolus administration after discontinuing isoflurane.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

* it is a randomized double blinded study
* Population of study:

Adult male and female patients undergoing single or double level lumbar disc laminectomy, discectomy and /or fixation.

recruitment of cases will be started after getting approval of ethical committee in our faculty (done and its number is N-56-2022/MD) and registration in clinicaltrials.gov and getting a unique number

\- Study location: This study will be set at neurosurgery theater, kasr alainy Hospital, Cairo University.

* Methodology in details: On arrival to the operating room, standard monitoring equipment will be applied, including electrocardiography (ECG), automated non-invasive blood pressure (NIBP), pulse oximetry and baseline readings will be recorded. Peripheral IV access will be inserted. Antibiotic and antiemetic will be given preoperatively. Entropy (GE Entropy healthcare) monitoring which is a valuable tool for measuring depth of anesthesia will be used, Response entropy (RE) and state entropy (SE) will be monitored using specific entropy sensors that will be placed on the patient's forehead according to the manufacturer's instructions.
* No sedative premedication will be given. Induction of general anesthesia will be done by propofol 2-3mg/kg, fentanyl 2ug/kg and endotracheal intubation will be facilitated by atracurium 0.5 mg/kg. Anesthesia will be maintained by isoflurane 1.2 % and atracurium 0.1 mg/kg/30min, morphine 0.1 mg/kg I.V will be given for intra and post -operative analgesia .Near the end of the end of the surgery, the study population will be randomized to three groups.
* . Group A will receive aminophylline loading dose 5mg/kg on a 50 cm syringe using syringe pump over 5 minutes and maintenance dose 1.5 mg/kg/hr as a continuous infusion half an hour before discontinuation of isoflurane, and after discontinuation of isoflurane a 5 cm syringe of saline will be given over 5 minutes . Group B will receive a 50 cm syringe of saline using syringe pump over 5 minutes and maintenance continuous infusion of saline half an hour before discontinuation of isoflurane, and after discontinuation of isoflurane a 5cm syringe of aminophylline bolus 5mg\\kg will be given over 5 minutes. On the other hand, group C will receive a 50 cm syringe of saline using syringe pump over 5 minutes and maintenance continuous infusion of saline half an hour before discontinuation of isoflurane, and after discontinuation of isoflurane a 5 cm syringe of saline will be given. These syringes will be prepared by an independent anesthesiologist and contain either aminophylline or a similar volume of normal saline. Recovery and data collection will be assessed by a second anesthesiologist who will not be aware of the group to which the patient will be allocated, also the patients will not know to which group they will be allocated. Entropy values, heart rate, blood pressure will be monitored in all patients before and every 5 minutes after injection of the test drug till half an hour after extubation. The following variables will be measured in all groups eye -opening in response to vocal request and time to extubation after discontinuation of anesthetic agent.
* Entropy will be used to monitor the depth of anesthesia using frontal electromyography through measuring irregularity of signals. High entropy values indicate high irregularity of signals which signifies that the patient is awake. A more regular signal produce low entropy values which can be associated with low probability of consciousness, so we will use it to assess the speed of return of conscious level after discontinuation of isoflurane.
* At the end of surgery, anesthetic gases will be discontinued and patients will be ventilated with 100% O2. For the antagonism of muscle relaxation, neostigmine 0.05mg/kg and atropine 0.01mg/kg will be given

sample size :

Power analysis was performed using one-way ANOVA test to detect at least 20% difference in time to extubation as the primary outcome of our study. Based on previous study(10); the mean ± SD time to extubation in the single shot aminophylline group was 6.6 ± 2.47 minutes.

At an α error of 0.05 and power of 0.8. A minimum of 93 patients was calculated. The sample will be increased 99 patients (33 patients per arm) for the possible dropouts. Sample size was calculated using G\*Power 3 software.

11- Statistical analysis

The statistical package for the social sciences version 23 (SPSS, Inc, Chicago, IL, USA) will be used for statistical analysis. Descriptive statistics will be done for quantitative data by mean \& standard deviation (SD), while they are done for categorical data by number and percentage. Studies will be done to calculate the inter and intra-observer variability. The level of significance is taken at P value\<0.05 to exclude false positive results

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anesthesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

DOUBLE

Participants Caregivers
drugs will be prepared by another person who is not giving drugs or collecting data

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

group A

will receive aminophylline loading dose 5mg/kg on a 50 cm syringe using syringe pump over 5 minutes and maintenance dose 1.5 mg/kg/hr as a continuous infusion half an hour before discontinuation of isoflurane, and after discontinuation of isoflurane a 5 cm syringe of saline will be given over 5 minutes

Group Type ACTIVE_COMPARATOR

Aminophylline bolus then infusion

Intervention Type DRUG

half an hour before discontinuation of isoflurane

group B

will receive a 50 cm syringe of saline using syringe pump over 5 minutes and maintenance continuous infusion of saline half an hour before discontinuation of isoflurane, and after discontinuation of isoflurane a 5cm syringe of aminophylline bolus 5mg\\kg will be given over 5 minutes

Group Type ACTIVE_COMPARATOR

aminophylline bolus

Intervention Type DRUG

after discontinuation of isoflurane

group C

will receive a 50 cm syringe of saline using syringe pump over 5 minutes and maintenance continuous infusion of saline half an hour before discontinuation of isoflurane, and after discontinuation of isoflurane a 5 cm syringe of saline will be given

Group Type PLACEBO_COMPARATOR

normal saline

Intervention Type DRUG

given as placebo

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Aminophylline bolus then infusion

half an hour before discontinuation of isoflurane

Intervention Type DRUG

aminophylline bolus

after discontinuation of isoflurane

Intervention Type DRUG

normal saline

given as placebo

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

ASA I-II. 20-50 years old patients. Both sexes Patients undergoing single or double level lumbar laminectomy ,discectomy and/or fixation

Exclusion Criteria

Contraindications to the use of aminophylline as cardiac patients, patients with renal impairment, hepatic dysfunction, hypo or hyperthyroidism and epilepsy.

Patients who have hypersensitivity to aminophylline Emergency operations. Operative time exceeding 5 hours
Minimum Eligible Age

21 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ahmed Hussein Sayed Hasan

lecturer of anesthesia , surgical ICU and pain managment

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kasr Alainy

Cairo, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ahmed H. Sayed, M.D

Role: CONTACT

+201068112464

Rania s. Fahmy, M.D

Role: CONTACT

+201270820372

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ahmed H. Sayed, M.D

Role: primary

+201068112464

Rania s. Fahmy, M.D

Role: backup

+21270820372

References

Explore related publications, articles, or registry entries linked to this study.

El Tahan MR. Effects of aminophylline on cognitive recovery after sevoflurane anesthesia. J Anesth. 2011 Oct;25(5):648-56. doi: 10.1007/s00540-011-1190-8. Epub 2011 Jul 14.

Reference Type BACKGROUND
PMID: 21755342 (View on PubMed)

Elsarrag M, Soldozy S, Patel P, Norat P, Sokolowski JD, Park MS, Tvrdik P, Kalani MYS. Enhanced recovery after spine surgery: a systematic review. Neurosurg Focus. 2019 Apr 1;46(4):E3. doi: 10.3171/2019.1.FOCUS18700.

Reference Type BACKGROUND
PMID: 30933920 (View on PubMed)

Wang Q, Fong R, Mason P, Fox AP, Xie Z. Caffeine accelerates recovery from general anesthesia. J Neurophysiol. 2014 Mar;111(6):1331-40. doi: 10.1152/jn.00792.2013. Epub 2013 Dec 26.

Reference Type BACKGROUND
PMID: 24375022 (View on PubMed)

Ghaffaripour S, Khosravi MB, Rahimi A, Sahmedini MA, Chohedri A, Mahmoudi H, Kazemi MR. The effects of Aminophylline on clinical recovery and bispectral index in patients anesthetized with total intravenous anaesthesia. Pak J Med Sci. 2014 Nov-Dec;30(6):1351-5. doi: 10.12669/pjms.306.5853.

Reference Type BACKGROUND
PMID: 25674137 (View on PubMed)

Wang HL, Tang SH, Wang XQ, Gong WH, Liu XM, Lei WF. Doxapram hastens the recovery following total intravenous anesthesia with dexmedetomidine, propofol and remifentanil. Exp Ther Med. 2015 Apr;9(4):1518-1522. doi: 10.3892/etm.2015.2249. Epub 2015 Feb 2.

Reference Type BACKGROUND
PMID: 25780462 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

N-56-2022/MD

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.